• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-乙酰半胱氨酸可调节系统性红斑狼疮患者淋巴细胞中线粒体电子传递链复合物 I 的活性。

Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus.

机构信息

1 Division of Rheumatology, Department of Medicine, College of Medicine, State University of New York , Upstate Medical University, Syracuse, New York.

出版信息

Antioxid Redox Signal. 2014 Jul 1;21(1):56-65. doi: 10.1089/ars.2013.5702. Epub 2014 Apr 23.

DOI:10.1089/ars.2013.5702
PMID:24673154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4048573/
Abstract

AIMS

Systemic lupus erythematosus (SLE) patients' peripheral blood lymphocytes (PBL) show mitochondrial dysfunction and oxidative stress. To determine the electrochemical bases of mitochondrial dysfunction, we measured electron transport chain (ETC) activity and its regulation by N-acetylcysteine (NAC) that reversed glutathione depletion and improved disease activity in SLE. ETC activity was assessed in PBL of 69 SLE patients and 37 healthy donors. Negatively isolated T cells were examined in 7 SLE patients, 11 healthy donors, and 10 nonlupus inflammatory arthritis (IA) donors.

RESULTS

O₂ consumption (in nmol/ml/min) by lupus PBL was increased at baseline (SLE: 2.492±0.196, control: 2.137±0.153; p=0.027) and with complex IV substrates (SLE: 7.722±0.419, control: 7.006±0.505; p=0.028). SLE PBL consumed more O₂ upon in-chamber T-cell activation (p=0.012). After overnight T-cell stimulation, ETC activity of SLE PBL was 2.27-fold increased through complex I (SLE: 1.606±0.273, control: 0.709±0.169; p=0.001) and, to a lesser extent, through complex IV. Likewise, complex I activity was elevated in negatively isolated "untouched" T cells of SLE patients (1.816±0.180) relative to healthy controls (0.917±0.094; p=0.0003) and IA disease controls studied in parallel (1.057±0.199; p=0.0308). NAC diminished O₂ consumption through complex I and H₂O₂ levels both in SLE and in control PBL.

INNOVATION

O₂ consumption was found to be increased in SLE patients' PBL relative to control subjects evaluated in parallel. ETC complex I is identified as the main source of oxidative stress in SLE.

CONCLUSIONS

Lupus PBL exhibit increased O₂ consumption through mitochondrial ETC complex I that is inhibited by NAC, which may have therapeutic efficacy through reducing oxidative stress in SLE.

摘要

目的

系统性红斑狼疮(SLE)患者外周血淋巴细胞(PBL)存在线粒体功能障碍和氧化应激。为了确定线粒体功能障碍的电化学基础,我们测量了电子传递链(ETC)的活性,以及 N-乙酰半胱氨酸(NAC)对其的调节作用,NAC 可以逆转谷胱甘肽耗竭并改善 SLE 患者的疾病活动度。ETC 活性在 69 名 SLE 患者和 37 名健康供体的 PBL 中进行了评估。在 7 名 SLE 患者、11 名健康供体和 10 名非狼疮性炎症性关节炎(IA)供体的阴性分离 T 细胞中进行了检查。

结果

狼疮 PBL 的 O₂消耗(nmol/ml/min)在基线时增加(SLE:2.492±0.196,对照:2.137±0.153;p=0.027),并且在使用 IV 复合物底物时增加(SLE:7.722±0.419,对照:7.006±0.505;p=0.028)。SLE PBL 在室内 T 细胞激活时消耗更多的 O₂(p=0.012)。经过一夜的 T 细胞刺激后,SLE PBL 的 ETC 活性通过复合物 I 增加了 2.27 倍(SLE:1.606±0.273,对照:0.709±0.169;p=0.001),并且在一定程度上通过复合物 IV 增加。同样,与健康对照组(0.917±0.094;p=0.0003)和并行研究的 IA 疾病对照组(1.057±0.199;p=0.0308)相比,SLE 患者阴性分离的“未触及”T 细胞中的复合物 I 活性也升高。(1.816±0.180)。NAC 可降低 SLE 和对照 PBL 中通过复合物 I 的 O₂消耗和 H₂O₂水平。

创新点

与并行评估的对照组相比,我们发现 SLE 患者的 PBL 中 O₂消耗增加。ETC 复合物 I 被鉴定为 SLE 中氧化应激的主要来源。

结论

狼疮 PBL 通过线粒体 ETC 复合物 I 表现出增加的 O₂消耗,NAC 可抑制该复合物 I,这可能通过减少 SLE 中的氧化应激而具有治疗功效。

相似文献

1
Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus.N-乙酰半胱氨酸可调节系统性红斑狼疮患者淋巴细胞中线粒体电子传递链复合物 I 的活性。
Antioxid Redox Signal. 2014 Jul 1;21(1):56-65. doi: 10.1089/ars.2013.5702. Epub 2014 Apr 23.
2
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.持续性线粒体超极化、活性氧中间体生成增加以及细胞质碱化是系统性红斑狼疮患者白细胞介素-10信号改变的特征。
J Immunol. 2002 Jul 15;169(2):1092-101. doi: 10.4049/jimmunol.169.2.1092.
3
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.N-乙酰半胱氨酸通过阻断系统性红斑狼疮患者T细胞中的雷帕霉素靶蛋白来降低疾病活动度:一项随机、双盲、安慰剂对照试验。
Arthritis Rheum. 2012 Sep;64(9):2937-46. doi: 10.1002/art.34502.
4
Comprehensive metabolome analyses reveal -acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin.全面代谢组分析揭示了系统性红斑狼疮中犬尿氨酸的N-乙酰半胱氨酸反应性积累:对雷帕霉素作用靶点激活的影响。
Metabolomics. 2015;11(5):1157-1174. doi: 10.1007/s11306-015-0772-0. Epub 2015 Jan 20.
5
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.系统性红斑狼疮患者的线粒体超极化和ATP耗竭
Arthritis Rheum. 2002 Jan;46(1):175-90. doi: 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H.
6
Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study.系统性红斑狼疮外周血淋巴细胞上IL-2R、IL-4R、IL-6R的表达及其与疾病活动度的相关性:一项前瞻性研究
J Clin Pathol. 1996 Aug;49(8):660-3. doi: 10.1136/jcp.49.8.660.
7
Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.系统性红斑狼疮患者外周血淋巴细胞体外免疫球蛋白的产生:辅助性T细胞缺陷与B细胞反应性亢进
Clin Exp Immunol. 1981 Jun;44(3):548-54.
8
Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus.系统性红斑狼疮患者淋巴细胞中细胞周期蛋白B1和细胞周期蛋白依赖性激酶抑制剂p21的表达
J Rheumatol. 2002 Dec;29(12):2537-44.
9
Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.类风湿性关节炎和系统性红斑狼疮中的淋巴因子产生
J Rheumatol. 1988 Nov;15(11):1639-42.
10
Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity.系统性红斑狼疮患者外周血淋巴细胞中白细胞介素-2受体的表达:与临床活动的关系
Clin Immunol Immunopathol. 1988 Jun;47(3):354-62. doi: 10.1016/s0090-1229(88)80012-6.

引用本文的文献

1
Aberrant glucose metabolism drives dysfunction of CD4 T cells in systemic lupus erythematosus and disease flares.异常的葡萄糖代谢驱动系统性红斑狼疮中CD4 T细胞功能障碍及疾病发作。
Cent Eur J Immunol. 2025;50(1):13-23. doi: 10.5114/ceji.2025.149252. Epub 2025 Apr 9.
2
Immunometabolism in systemic lupus erythematosus.系统性红斑狼疮中的免疫代谢
Nat Rev Rheumatol. 2025 Jun 16. doi: 10.1038/s41584-025-01267-0.
3
Overview of Oxidative Stress in Systemic Lupus Erythematosus.系统性红斑狼疮中的氧化应激概述
Antioxidants (Basel). 2025 Mar 1;14(3):303. doi: 10.3390/antiox14030303.
4
Exploring mitochondrial and ferroptotic mechanisms for systemic lupus erythematosus biomarker identification and therapy.探索线粒体和铁死亡机制以用于系统性红斑狼疮生物标志物的识别与治疗。
Sci Rep. 2025 Mar 17;15(1):9140. doi: 10.1038/s41598-025-93872-y.
5
Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Systemic Lupus Erythematosus via Glucose Metabolism of CD4T Cells.人脐带间充质干细胞通过CD4T细胞的糖代谢治疗系统性红斑狼疮
Stem Cell Rev Rep. 2025 May;21(4):1013-1033. doi: 10.1007/s12015-025-10848-1. Epub 2025 Feb 20.
6
Intricating connections: the role of ferroptosis in systemic lupus erythematosus.错综复杂的联系:铁死亡在系统性红斑狼疮中的作用
Front Immunol. 2025 Feb 4;16:1534926. doi: 10.3389/fimmu.2025.1534926. eCollection 2025.
7
Screening for Mitochondrial tRNA Variants in 200 Patients with Systemic Lupus Erythematosus.200例系统性红斑狼疮患者线粒体tRNA变体的筛查
Hum Hered. 2024;89(1):84-97. doi: 10.1159/000542357. Epub 2024 Nov 13.
8
Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential.系统性红斑狼疮中的线粒体功能障碍:见解与治疗潜力
Diseases. 2024 Sep 23;12(9):226. doi: 10.3390/diseases12090226.
9
The immunology of systemic lupus erythematosus.系统性红斑狼疮的免疫学。
Nat Immunol. 2024 Aug;25(8):1332-1343. doi: 10.1038/s41590-024-01898-7. Epub 2024 Jul 15.
10
Redox Pathogenesis in Rheumatic Diseases.风湿性疾病中的氧化还原发病机制。
ACR Open Rheumatol. 2024 Jun;6(6):334-346. doi: 10.1002/acr2.11668. Epub 2024 Apr 25.

本文引用的文献

1
HRES-1/Rab4 promotes the formation of LC3(+) autophagosomes and the accumulation of mitochondria during autophagy.HRES-1/Rab4 促进自噬过程中 LC3(+)自噬体的形成和线粒体的积累。
PLoS One. 2014 Jan 3;9(1):e84392. doi: 10.1371/journal.pone.0084392. eCollection 2014.
2
Oxidative stress in the pathology and treatment of systemic lupus erythematosus.氧化应激在系统性红斑狼疮的发病机制和治疗中的作用。
Nat Rev Rheumatol. 2013 Nov;9(11):674-86. doi: 10.1038/nrrheum.2013.147. Epub 2013 Oct 8.
3
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.HRES-1/Rab4介导的动力相关蛋白1(Drp1)缺失会损害线粒体稳态,是系统性红斑狼疮(SLE)治疗的一个靶点。
Ann Rheum Dis. 2014 Oct;73(10):1888-97. doi: 10.1136/annrheumdis-2013-203794. Epub 2013 Jul 29.
4
Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.系统性红斑狼疮患者淋巴细胞中线粒体功能障碍的评估
Methods Mol Biol. 2012;900:61-89. doi: 10.1007/978-1-60761-720-4_4.
5
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.N-乙酰半胱氨酸通过阻断系统性红斑狼疮患者T细胞中的雷帕霉素靶蛋白来降低疾病活动度:一项随机、双盲、安慰剂对照试验。
Arthritis Rheum. 2012 Sep;64(9):2937-46. doi: 10.1002/art.34502.
6
Pharmacotherapy of systemic lupus erythematosus.系统性红斑狼疮的药物治疗。
Expert Opin Pharmacother. 2009 Jun;10(9):1481-94. doi: 10.1517/14656560902971003.
7
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.雷帕霉素哺乳动物靶蛋白的激活通过HRES-1/Rab4调节的溶酶体降解控制狼疮T细胞中TCRζ的丢失。
J Immunol. 2009 Feb 15;182(4):2063-73. doi: 10.4049/jimmunol.0803600.
8
Metabolic control of T cell activation and death in SLE.系统性红斑狼疮中T细胞活化与死亡的代谢调控
Autoimmun Rev. 2009 Jan;8(3):184-9. doi: 10.1016/j.autrev.2008.07.041. Epub 2008 Aug 21.
9
Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage.氧化应激状态下牛心脏线粒体中的复合物I在75 kDa亚基的半胱氨酸-531和半胱氨酸-704上发生谷胱甘肽化修饰:半胱氨酸残基在减少氧化损伤中的潜在作用
J Biol Chem. 2008 Sep 5;283(36):24801-15. doi: 10.1074/jbc.M803432200. Epub 2008 Jul 8.
10
Pharmacological treatment of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的药物治疗
Int J Chron Obstruct Pulmon Dis. 2006;1(4):409-23. doi: 10.2147/copd.2006.1.4.409.